- Home
- ETON vs VATE Comparison
ETON vs VATE Comparison
Compare ETON & VATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ETON | VATE |
|---|---|---|
| Founded | 2017 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 103.5M |
| IPO Year | 2018 | 1996 |
Fundamental Metrics
Financial Performance| Metric | ETON | VATE |
|---|---|---|
| Price | $58.61 | $7.76 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $39.33 | N/A |
| AVG Volume (30 Days) | ★ 390.1K | 93.5K |
| Earning Date | 05-14-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.41 | N/A |
| Revenue | $79,950,000.00 | ★ $1,246,000,000.00 |
| Revenue This Year | $40.90 | N/A |
| Revenue Next Year | $47.23 | N/A |
| P/E Ratio | $145.10 | ★ N/A |
| Revenue Growth | ★ 104.94 | 12.55 |
| 52 Week Low | $14.27 | $3.75 |
| 52 Week High | $66.37 | $21.30 |
Technical Indicators
Market Signals| Indicator | ETON | VATE |
|---|---|---|
| Relative Strength Index (RSI) | 54.72 | 50.03 |
| Support Level | $15.75 | $6.48 |
| Resistance Level | $66.37 | $8.23 |
| Average True Range (ATR) | 2.74 | 0.53 |
| MACD | -0.44 | 0.12 |
| Stochastic Oscillator | 69.00 | 73.03 |
Price Performance
Historical ComparisonAbout ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments. Its segments include Infrastructure, Life Sciences and Spectrum, and Other segment. Through its subsidiaries it provides fully integrated structural and steel construction services; supports healthcare and biotechnology product development; and operates Over-The-Air (OTA) broadcasting stations across the United States (U.S.) including Puerto Rico.